Fig. 1From: Surfactant nanovesicles for augmented antibacterial activity against carbapenemase resistant enterobacteriaceae and extended spectrum beta-lactamases producing bacteria: in vitro and in vivo evaluation(a) The distribution of E. coli and K. pneumoniae isolates according to the clinical sources. (b) A representative photomicrograph of K. pneumoniae capsule. The bacterial cells appear as purple cells surrounded by clear halo. *c line: sample from the Central line. *biological fluid samples were synovial fluidsBack to article page